Physician

Jason Ayres, MD

According to 2025 Medicare claims, Jason Ayres, MD (NPI: 1972566776) practices family practice in the Gadsden, AL market, with the plurality of this provider's patient population coming from Etowah, AL. This provider's primary affiliated billing organization is PRIME HEALTHCARE SERVICES-GADSDEN PHYSICIAN MANAGEMENT LLC (NPI: 1356731467; TIN: 47-2253254) and primary practice location at 35907-7907. Ayres is affiliated with the CHSPSC ACO 8, LLC (ACO ID: A3715), participating under the MSSP model.

Ayres' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 354 traditional Medicare patients, billed 4,378 HCPCS/CPT codes, and received $142,822 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 19,267 prescription claims across 1,152 beneficiaries totaling $1,702,188 in drug costs, led by Ozempic (Semaglutide). DME data shows 157 claims. Open Payments data shows 27 records totaling $572. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $951,582 to $1,702,188. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $29,351 to $30,724.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	646	5,323	$142,871
2016	616	4,923	$127,125
2017	481	3,769	$110,023
2018	449	3,750	$103,082
2019	460	4,297	$130,819
2020	453	3,953	$155,713
2021	409	2,901	$123,076
2022	389	3,426	$150,187
2023	374	4,342	$163,112
2024	354	4,378	$142,822

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,033	15,681	$951,582
2016	1,075	16,588	$1,029,898
2017	1,072	17,720	$1,172,060
2018	988	16,794	$1,253,941
2019	927	16,668	$1,367,859
2020	983	17,418	$1,294,263
2021	1,020	18,653	$1,458,908
2022	1,018	18,314	$1,535,291
2023	1,036	18,171	$1,753,081
2024	1,152	19,267	$1,702,188

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	135	556	$18,564
2016	118	410	$12,402
2017	54	229	$3,623
2018	34	129	$2,084
2019	22	105	$3,211
2020	N/R	56	$3,206
2021	12	125	$8,226
2022	11	108	$6,650
2023	N/R	67	$9,747
2024	N/R	157	$22,712

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	269	269	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	302	501	$77
99497	Advance care planning, first 30 minutes	105	105	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	169	299	$54
36415	Insertion of needle into vein for collection of blood sample	219	313	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	257	7,886	$259,160
Eliquis	Apixaban	196	8,112	$150,258
Farxiga	Dapagliflozin Propanediol	175	6,556	$121,776
Jardiance	Empagliflozin	91	4,498	$86,142
Mounjaro	Tirzepatide	72	2,358	$83,345

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	43	$18,058
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	13	$1,975
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	35	$1,244
A7030	Full face mask used with positive airway pressure device, each	N	N/R	12	$870
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	11	$209

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$572	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jason Ayres, MD?

Tedicare shows public-source Medicare data for Jason Ayres, MD (NPI 1972566776), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason Ayres, MD have ACO affiliation data?

Jason Ayres, MD is shown with ACO affiliation data for CHSPSC ACO 8, LLC (MSSP, ACO ID A3715).

What billing organization is linked to Jason Ayres, MD?

Jason Ayres, MD is linked to PRIME HEALTHCARE SERVICES-GADSDEN PHYSICIAN MANAGEMENT LLC (billing NPI 1356731467) in the available physician profile data.

Does Jason Ayres, MD have Open Payments data?

Jason Ayres, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.